<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35056561</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Cases of Acute Flaccid Paralysis Associated with Coxsackievirus A2: Findings of a 20-Year Surveillance in the Russian Federation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms10010112</ELocationID><Abstract><AbstractText>Surveillance for acute flaccid paralysis syndrome (AFP) in children under 15 is the backbone of the Global Polio Eradication Initiative. Laboratory examination of stool samples from AFP cases allows the detection of, along with polioviruses, a variety of non-polio enteroviruses (NPEV). The etiological significance of these viruses in the occurrence of AFP cases has been definitively established only for enteroviruses A71 and D68. Enterovirus Coxsackie A2 (CVA2) is most often associated with vesicular pharyngitis and hand, foot and mouth disease. Among 7280 AFP cases registered in Russia over 20 years (2001-2020), CVA2 was isolated only from five cases. However, these included three children aged 3 to 4 years, without overt immune deficiency, immunized with 4-5 doses of poliovirus vaccine in accordance with the National Vaccination Schedule. The disease resulted in persistent residual paralysis. Clinical and laboratory data corresponded to poliomyelitis developing during poliovirus infection. These findings are compatible with CVA2 being the cause of AFP. Molecular analysis of CVA2 from these patients and a number of AFP cases in other countries did not reveal association with a specific phylogenetic group, suggesting that virus genetics is unlikely to explain the pathogenic profile. The overall results highlight the value of AFP surveillance not just for polio control but for studies of uncommon AFP agents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ivanova</LastName><ForeName>Olga E</ForeName><Initials>OE</Initials><Identifier Source="ORCID">0000-0003-1784-4827</Identifier><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Organization and Technology of Production of Immunobiological Preparations, Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakaryan</LastName><ForeName>Armen K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, 119121 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morozova</LastName><ForeName>Nadezhda S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Federal Budget Institution of Healthcare of Rospotrebnadzor "Center for Hygiene and Epidemiology in Moscow", 129626 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakulenko</LastName><ForeName>Yulia A</ForeName><Initials>YA</Initials><Identifier Source="ORCID">0000-0003-2791-1835</Identifier><AffiliationInfo><Affiliation>Martsinovsky Institute of Meidcal Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eremeeva</LastName><ForeName>Tatyana P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlovskaya</LastName><ForeName>Liubov I</ForeName><Initials>LI</Initials><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Organization and Technology of Production of Immunobiological Preparations, Institute for Translational Medicine and Biotechnology, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baykova</LastName><ForeName>Olga Y</ForeName><Initials>OY</Initials><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shustova</LastName><ForeName>Elena Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Federal State Autonomous Scientific Institution "Chumakov Federal Center for Research and Development of Immune-and-Biological Products of the Russian Academy of Sciences" (Institute of Poliomyelitis) (FSASI "Chumakov FSC R&amp;D IBP RAS"), 108819 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikhailova</LastName><ForeName>Yulia M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Federal Budget Institution of Healthcare of Rospotrebnadzor "Center for Hygiene and Epidemiology in Moscow", 129626 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanenkova</LastName><ForeName>Natalia I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Saint-Petersburg Pasteur Institute, 197101 Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rozaeva</LastName><ForeName>Nadezhda R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Saint-Petersburg Pasteur Institute, 197101 Saint-Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzhaparidze</LastName><ForeName>Natela I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Federal Budgetary Institution of Healthcare of Rospotrebnadzor "Center for Hygiene and Epidemiology in the Vladimir Region", 600005 Vladimir, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novikova</LastName><ForeName>Nadezhda A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 603950 Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zverev</LastName><ForeName>Vladimir V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 603950 Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golitsyna</LastName><ForeName>Lyudmila N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 603950 Nizhny Novgorod, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukashev</LastName><ForeName>Alexander N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Martsinovsky Institute of Meidcal Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>19-15-00055</GrantID><Agency>Russian Science Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute flaccid paralysis (AFP)</Keyword><Keyword MajorTopicYN="N">coxsackievirus A2 (CV-A2)</Keyword><Keyword MajorTopicYN="N">epidemiological surveillance</Keyword><Keyword MajorTopicYN="N">non-polio enteroviruses</Keyword><Keyword MajorTopicYN="N">poliomyelitis</Keyword><Keyword MajorTopicYN="N">polioviruses</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35056561</ArticleId><ArticleId IdType="pmc">PMC8780984</ArticleId><ArticleId IdType="doi">10.3390/microorganisms10010112</ArticleId><ArticleId IdType="pii">microorganisms10010112</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>International Committee on Taxonomy of Viruses (ICTV)  [(accessed on 27 October 2021)].  Available online:  https://ictv.global/taxonomy/</Citation></Reference><Reference><Citation>Chiang K.-L., Wei S.-H., Fan H.-C., Chou Y.-K., Yang J.-Y. Outbreak of recombinant coxsackievirus A2 infection and polio-like paralysis of children, Taiwan, 2014. Pediatr. Neonatol. 2019;60:95–99. doi: 10.1016/j.pedneo.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2018.02.003</ArticleId><ArticleId IdType="pubmed">29503223</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Gao H.-H., Zhang O., Liu Y.-J., Tao R., Cheng Y.-P., Shu O., Shang S.-Q. Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou, China. Sci. Rep. 2016;6:35388. doi: 10.1038/srep35388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35388</ArticleId><ArticleId IdType="pmc">PMC5067559</ArticleId><ArticleId IdType="pubmed">27752104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Zhang Y., Yan D., Zhu S., Wang D., Ji T., Li X., Song Y., Gu X., Xu W. Two genotypes of coxsackievirus A2 associated with hand, foot, and mouth disease circulating in China since 2008. PLoS ONE. 2016;11:e0169021. doi: 10.1371/journal.pone.0169021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169021</ArticleId><ArticleId IdType="pmc">PMC5193457</ArticleId><ArticleId IdType="pubmed">28030650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H., Fan H., Lu P.-X., Zhang X.-F., Ai J., Shi C., Huo X., Bao C.-J., Shan J., Jin Y. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: Epidemiology, etiology, and disease burden.  [(accessed on 29 December 2021)];BMC Infect. Dis. 2019 19:79.  doi: 10.1186/s12879-018-3659-7. Available online:  https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3659-7</ArticleId><ArticleId IdType="doi">10.1186/s12879-018-3659-7</ArticleId><ArticleId IdType="pmc">PMC6341624</ArticleId><ArticleId IdType="pubmed">30669973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.P., Huang Y.C., Li W.C., Chiu C.H., Huang C.G., Tsao K.C., Lin T.Y. Comparison of clinical features between Coxsackievirus A2 and Enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: A children’s hospital experience. Microbiol. Immunol. Infect. 2010;43:99–104. doi: 10.1016/S1684-1182(10)60016-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1684-1182(10)60016-3</ArticleId><ArticleId IdType="pubmed">20457425</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C., Siegrist F., Petty T.J., Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013;14:282–293. doi: 10.1016/j.meegid.2012.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendig J.W.A., O’Brien P.S., Muir P., Porter H.J., ECaul E.O. Enterovirus sequences resembling Coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis. J. Med. Virol. 2001;64:482–486. doi: 10.1002/jmv.1075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1075</ArticleId><ArticleId IdType="pubmed">11468733</ArticleId></ArticleIdList></Reference><Reference><Citation>Moleta L., Saloum K., Marque-Juillet S., Garbarg-Chenon A., Henquell C., Schuffenecker I., Peigue-Lafeuille H., Rozenberg F., Mirand A. Enterovirus infections in hospitals of Ile de France region over 2013. J. Clin. Virol. 2016;74:37–42. doi: 10.1016/j.jcv.2015.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.11.024</ArticleId><ArticleId IdType="pubmed">26655266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohara N., Kaneko M., Nishibori T., Sato K., Furukawa T., Koike T., Sone H., Kaneko K., Kamoi K. Fulminant type 1 diabetes mellitus associated with Coxsackie virus type A2 infection: A case report and literature review. Intern. Med. 2016;55:643–646. doi: 10.2169/internalmedicine.55.5292.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.55.5292</ArticleId><ArticleId IdType="pubmed">26984083</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx A., Glass J.D., Sutter R.W. Differential diagnosis of Acute Flaccid Paralysis and its role in poliomyelitis. Epidemiol. Rev. 2000;22:298–316. doi: 10.1093/oxfordjournals.epirev.a018041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a018041</ArticleId><ArticleId IdType="pubmed">11218380</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivé J.M., Castillo C., Castro R.G., de Quadros C.A. Epidemiologic study of Guillain-Barre syndrome in children &lt;15 years of age in Latin America. J. Infect. Dis. 1997;175((Supple. 1)):S160–S164. doi: 10.1093/infdis/175.Supplement_1.S160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/175.Supplement_1.S160</ArticleId><ArticleId IdType="pubmed">9203710</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Assembly  . Global Eradication of Poliomyelitis by the Year 2000. World Health Organization; Geneva, Switzerland: 1988.  [(accessed on 29 December 2021)].  WHA Resolution No. WHA41.28. Available online:  https://apps.who.int/iris/handle/10665/164531.</Citation></Reference><Reference><Citation>Chouikha A., Rezig D., Driss N., Abdelkhalek I., Ben Yahia A., Touzi H., Meddeb Z., Ben Farhat E., Yahyaoui M., Triki H. Circulation and molecular epidemiology of enteroviruses in paralyzed, immunodeficient and healthy individuals in Tunisia, a country with a polio-free status for decades. Viruses. 2021;13:380. doi: 10.3390/v13030380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030380</ArticleId><ArticleId IdType="pmc">PMC7997211</ArticleId><ArticleId IdType="pubmed">33673590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieczorek M., Krzysztoszek A. Molecular characterization of enteroviruses isolated from acute flaccid paralysis cases in Poland, 1999–2014. Pol. J. Microbiol. 2016;65:443–450. doi: 10.5604/17331331.1227670.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/17331331.1227670</ArticleId><ArticleId IdType="pubmed">28735328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrinelli L., Galli C., Primache V., Bubba L., Buttinelli G., Stefanelli P., Pariani E., Binda S. Emerging non-polio enteroviruses recognized in the framework of the acute flaccid paralyses (AFP) surveillance system in Northern Italy, 2016–2018. Int. J. Infect. Dis. 2021;106:36–40. doi: 10.1016/j.ijid.2021.03.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.03.057</ArticleId><ArticleId IdType="pubmed">33771675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao M.M.A., Apostol L.N., de Quiroz-Castro M., Jee Y., Roque V., Mapue M., Navarro F.M., Fe Tabada C., Tandoc A. Non-polio enteroviruses among healthy children in the Philippines. BMC Public Health. 2020;20:167. doi: 10.1186/s12889-020-8284-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-8284-x</ArticleId><ArticleId IdType="pmc">PMC6998086</ArticleId><ArticleId IdType="pubmed">32013921</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   Manual for the Virological Investigation of Polio. 4th ed. WHO; Geneva, Switzerland: 2004.  [(accessed on 27 October 2021)].  Available online:  http://whqlibdoc.who.int/hq/2004/WHO_IVB_04.10.pdf.</Citation></Reference><Reference><Citation>Suresh S., Rawlinson W.D., Andrews P.I., Stelzer-Braid S. Global epidemiology of nonpolio enteroviruses causing severe neurological complications: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:e2082. doi: 10.1002/rmv.2082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2082</ArticleId><ArticleId IdType="pubmed">31588651</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S.M.G., Koopmans M.P.G., van der Avoort H.G.A.M. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996–2011. Eur. J. Clin. Microbiol. Infect. Dis. 2013;32:1525–1531. doi: 10.1007/s10096-013-1906-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-013-1906-9</ArticleId><ArticleId IdType="pubmed">23780695</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N., LaMonte A., Oberste M.S., Pallansch M. Neonatal enterovirus infections reported to the National Enterovirus Surveillance System in the United States, 1983–2003. Pediatr. Infect. Dis. J. 2006;25:889–893. doi: 10.1097/01.inf.0000237798.07462.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000237798.07462.32</ArticleId><ArticleId IdType="pubmed">17006282</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Committee for the Certification of Wild Poliovirus Eradication in Hong Kong (NCC) Fifteen years of acute flaccid paralysis surveillance in Hong Kong: Findings from 1997 to 2011. J. Paediatr. Child Health. 2014;50:545–552. doi: 10.1111/jpc.12492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.12492</ArticleId><ArticleId IdType="pubmed">24528511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Kang B., Hwang S., Lee S.W., Cheon D.-S., Kim K., Jeong Y.-S., Hyeon J.-Y. Clinical and enterovirus findings associated with acute flaccid paralysis in the Republic of Korea during the recent Decade. J. Med. Virol. 2014;86:1584–1589. doi: 10.1002/jmv.23763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23763</ArticleId><ArticleId IdType="pubmed">24114945</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa I.P., de Lourdes Aguiar Oliveira M., Burlandy F.M., Machado R.S., Oliveira S.S., Tavares F.N., Gomes-Neto F., da Costa E.V., da Silva E.E. Molecular characterization and epidemiological aspects of non-polio enteroviruses isolated from acute flaccid paralysis in Brazil: A historical series (2005–2017) Emerg. Microbes Infect. 2020;9:2536–2546. doi: 10.1080/22221751.2020.1850181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1850181</ArticleId><ArticleId IdType="pmc">PMC7717866</ArticleId><ArticleId IdType="pubmed">33179584</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  Regional Office for Europe.  [(accessed on 27 October 2021)].  Available online:  http://data.euro.who.int/cisid/default.aspx?TabID=539511.</Citation></Reference><Reference><Citation>The Ministry of Health of the Russian Federation. The State Committee for Sanitary and Epidemiological Supervision of the Russian Federation  On Approval of the Poliomyelitis Eradication Program on the Territory of the Russian Federation.  [(accessed on 29 December 2021)]; Available online:  https://base.garant.ru/4120180/</Citation></Reference><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Flemister M.R., Brown B.A., Pallansch M.A. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 1999;37:1288–1293. doi: 10.1128/JCM.37.5.1288-1293.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.5.1288-1293.1999</ArticleId><ArticleId IdType="pmc">PMC84754</ArticleId><ArticleId IdType="pubmed">10203472</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Service for Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)  Program “Epidemiological Surveillance and Prevention of Enterovirus (Non-Polio) Infection for 2018–2022.  [(accessed on 29 December 2021)]; Available online:  https://fcgie.ru/download/koord_tsentr/%D0%AD%D0%92%D0%98%20%D0%9F%D0%A0%D0%9E%D0%93%D0%A0%D0%90%D0%9C%D0%9C%D0%90%2018-22.pdf.</Citation></Reference><Reference><Citation>Nix W.A., Oberste M.S., Pallansch M.A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol. 2006;44:2698–2704. doi: 10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 29 December 2021)].  Available online:  https://github.com/v-julia/GenAlignment.</Citation></Reference><Reference><Citation>Katoh K., Standley D.M. MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst010</ArticleId><ArticleId IdType="pmc">PMC3603318</ArticleId><ArticleId IdType="pubmed">23329690</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh B.Q., Schmidt H.A., Chernomor O., Schrempf D., Woodhams M.D., von Haeseler A., Lanfear R. 2 IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 2020;37:1530–1534. doi: 10.1093/molbev/msaa015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa015</ArticleId><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang D.P., Chernomor O., von Haeseler A., Minh B.Q., Vinh L.S. UFBoot2: Improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 2018;35:518–522. doi: 10.1093/molbev/msx281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msx281</ArticleId><ArticleId IdType="pmc">PMC5850222</ArticleId><ArticleId IdType="pubmed">29077904</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyaanamoorthy S., Minh B.Q., Wong T.K.F., von Haeseler A., Jermiin L.S. ModelFinder: Fast model selection for accurate phylogenetic estimates. Nat. Methods. 2017;14:587–589. doi: 10.1038/nmeth.4285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4285</ArticleId><ArticleId IdType="pmc">PMC5453245</ArticleId><ArticleId IdType="pubmed">28481363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A., Lam T.T., Carvalho L.M., Pybus O.G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) Virus Evol. 2016;2:vew007. doi: 10.1093/ve/vew007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vew007</ArticleId><ArticleId IdType="pmc">PMC4989882</ArticleId><ArticleId IdType="pubmed">27774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M.A., Lemey P., Baele G., Ayres D.L., Drummond A.J., Rambaut A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4:vew016. doi: 10.1093/ve/vey016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vey016</ArticleId><ArticleId IdType="pmc">PMC6007674</ArticleId><ArticleId IdType="pubmed">29942656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanfear R., Frandsen P.B., Wright A.M., Senfeld T., Calcott B. PartitionFinder 2: New Methods for Selecting Partitioned Models of Evolution for Molecular and Morphological Phylogenetic Analyses. Mol. Biol. Evol. 2016:msw260. doi: 10.1093/molbev/msw260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msw260</ArticleId><ArticleId IdType="pubmed">28013191</ArticleId></ArticleIdList></Reference><Reference><Citation>Baele G., Lemey P., Bedford T., Rambaut A., Suchard M.A., Alekseyenko A.V. Improving the Accuracy of Demographic and Molecular Clock Model Comparison While Accommodating Phylogenetic Uncertainty. Mol. Biol. Evol. 2012;29:2157–2167. doi: 10.1093/molbev/mss084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mss084</ArticleId><ArticleId IdType="pmc">PMC3424409</ArticleId><ArticleId IdType="pubmed">22403239</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 29 December 2021)].  Available online:  http://tree.bio.ed.ac.uk/software/tracer.</Citation></Reference><Reference><Citation> [(accessed on 29 December 2021)].  Available online:  http://tree.bio.ed.ac.uk/software/figtree/</Citation></Reference><Reference><Citation>World Health Organization (WHO)   Report of the Second Meeting of the Technical Consultation Group for Global Eradication of Poliomyelitis. WHO; Geneva, Switzerland: 1998.  [(accessed on 29 December 2021)].  WHO/EPI/GEN/98/04. Available online:  https://apps.who.int/iris/bitstream/handle/10665/63994/WHO_EPI_GEN_98.04.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Leschinskaya E.V., Latysheva I.N. Guidelines. Moscow: M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitis Them. M.P. Chumakov Russian Academy of Medical Sciences; Moscow, Russian: 1998. The Clinic, Diagnosis and Treatment of Acute Poliomyelitis.</Citation></Reference><Reference><Citation>Yen T.-Y., Huang Y.-P., Hsu Y.-L., Chang Y.-T., Lin H.-C., Wu H.-S., Hwang K.-P. A case of recombinant coxsackievirus A2 infection with neurological complications in Taiwan. J. Microbiol. Immunol. Infect. 2017;50:928–930. doi: 10.1016/j.jmii.2016.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2016.08.012</ArticleId><ArticleId IdType="pubmed">28082064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., Vasilenko S., Brodvarova I., Nikolova M., Gyurova S., et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 1979;60:329–340. doi: 10.1007/BF01317504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley C.M., Watson J.T., Nix W.A., Curns A.T., Rogers S.L., Brown B.A., Conover C., Dominguez S.R., Feikin D.R., The EV-D68 Working Group et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): A descriptive epidemiological investigation. Lancet Respir. Med. 2015;3:879–887. doi: 10.1016/S2213-2600(15)00335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Clusters of acute respiratory illness associated with human enterovirus 68—Asia, Europe, and United States, 2008–2010. MMWR Morb. Mortal. Wkly. Rep. 2011;60:1301–1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">21956405</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelman R., Schuenecker I., Van Leer-Buter C., Josset L., Niesters H.G.M., Lina B. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J. Clin. Virol. 2015;71:1–9. doi: 10.1016/j.jcv.2015.07.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.296</ArticleId><ArticleId IdType="pubmed">26364237</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Acute Flaccid Myelitis (AFM) 2020 Case Definition.  [(accessed on 27 October 2021)]; Available online:  https://wwwn.cdc.gov/nndss/conditions/acute-flaccid-myelitis/case-definition/2020/</Citation></Reference><Reference><Citation>Kramer R., Sabatier M., Wirth T., Pichon M., Lina B., Schuffenecker I., Josset L. Molecular diversity and biennial circulation of enterovirus D68: A systematic screening study in Lyon, France, 2010 to 2016. Eurosurveillance. 2018;23:1700711. doi: 10.2807/1560-7917.ES.2018.23.37.1700711.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.37.1700711</ArticleId><ArticleId IdType="pmc">PMC6144471</ArticleId><ArticleId IdType="pubmed">30229724</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson C., Ho Mi Fane B., Squires S.G. Acute flaccid myelitis in Canada, 2018 to 2019. Can. Commun. Dis. Rep. 2020;46:349–353. doi: 10.14745/ccdr.v46i10a07.</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v46i10a07</ArticleId><ArticleId IdType="pmc">PMC7723314</ArticleId><ArticleId IdType="pubmed">33315981</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonen-Tikka M.L., Hiekka A.K., Klemola P., Poussa T., Ludvigsson J., Korpela R., Vaarala O., Merja Roivainen M. Early human entero- virus infec-tions in healthy Swedish children participating in the PRODIA pilot study. J. Med. Virol. 2012;84:923–930. doi: 10.1002/jmv.23284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23284</ArticleId><ArticleId IdType="pubmed">22499016</ArticleId></ArticleIdList></Reference><Reference><Citation>Witso E., Palacios G., Cinek O., Stene L.C., Grinde B., Janowitz D., Lipkin W.I., Rønningen K.S. High prevalence of human entero- virus a infec-tions in natural circulation of human enteroviruses. J. Clin. Microbiol. 2006;44:4095–4100. doi: 10.1128/JCM.00653-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00653-06</ArticleId><ArticleId IdType="pmc">PMC1698346</ArticleId><ArticleId IdType="pubmed">16943351</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt E., Harvala H., Österback R., Sreenu V.B., Thomson E., Waris M., Simmonds P. Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: A potential role of recombination in emergence and pathogenicity. J. Gen. Virol. 2015;96:1067–1079. doi: 10.1099/vir.0.000062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.000062</ArticleId><ArticleId IdType="pmc">PMC4631059</ArticleId><ArticleId IdType="pubmed">25614593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova O.E., Yarmolskaya M.S., Eremeeva T.P., Babkina G.M., Baykova O.Y., Akhmadishina L.V., Krasota A.Y., Kozlovskaya L.I., Lukashev A.N. Environmental Surveillance for Poliovirus and Other Enteroviruses: Long-Term Experience in Moscow, Russian Federation, 2004–2017. Viruses. 2019;11:424. doi: 10.3390/v11050424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050424</ArticleId><ArticleId IdType="pmc">PMC6563241</ArticleId><ArticleId IdType="pubmed">31072058</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   Manual for Virological Investigation of Poliomyelitis. WHO; Geneva, Switzerland: 1997.  [(accessed on 27 October 2021)].  WHO/EPI/GEN/97.1. Available online:  https://apps.who.int/iris/bitstream/handle/10665/62186/WHO_EPI_CDS_POLIO_90.1.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Ivanova O.E., Yurashko O.V., Eremeeva T.P., Baikova O.Y., Morozova N.S., Lukashev A.N. Adenovirus isolation rates in acute flaccid paralysis patients. J. Med. Virol. 2012;84:75–80. doi: 10.1002/jmv.22265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.22265</ArticleId><ArticleId IdType="pubmed">22052705</ArticleId></ArticleIdList></Reference><Reference><Citation>de Azevedo J.P.R., Nascimento L.R., Cortinovis M.C., Oliveira S.S., da Costa E.V., da Silva E.E. Characterization of species B adenoviruses isolated from fecal specimens taken from poliomyelitis-suspected cases. J. Clin. Virol. 2004;31:248–252. doi: 10.1016/j.jcv.2004.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2004.04.007</ArticleId><ArticleId IdType="pubmed">15494264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefi M., Nejati A., Zahraei S.M., Mahmoudi S., Parhizgari N., Farsani S.M.J., Mahmoodi M., Nategh R., Shahmahmoodi S. Enteroviruses and Adenoviruses in stool specimens of paralytic children- can they be the cause of paralysis?  [(accessed on 29 December 2021)];Iran. J. Microbiol. 2018 10:194–201. Available online:  http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6087694/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6087694</ArticleId><ArticleId IdType="pubmed">30112158</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad-Boubaker S., Joffret M.-L., Pérot P., Bessaud M., Meddeb Z., Touzi H., Delpeyroux F., Triki H., Eloit M. Metagenomic analysis identifies human adenovirus 31 in children with acute flaccid paralysis in Tunisia. Arch. Virol. 2019;164:747–755. doi: 10.1007/s00705-018-04141-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-018-04141-5</ArticleId><ArticleId IdType="pubmed">30631958</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   Polio Eradication Strategy 2022−2026: Executive Summary. World Health Organization; Geneva, Switzerland:  [(accessed on 27 October 2021)].  2021(WHO/Polio/21.04); Licence CC BY-NC-SA 3.0 IGO. Available online:  https://polioeradication.org/wp-content/uploads/2021/10/9789240031937-eng.pdf.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>